Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin

被引:37
作者
Rothman, RB [1 ]
Redmon, JB [1 ]
Raatz, SK [1 ]
Kwong, CA [1 ]
Swanson, JE [1 ]
Bantle, JP [1 ]
机构
[1] Univ Minnesota, Gen Clin Res Ctr, Dept Med, Div Endocrinol & Diabet, Minneapolis, MN USA
关键词
D O I
10.1016/S0002-9149(99)00896-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As expected on the basis of published research in both humans and animals, treatment with phentermine/fenfluramine lowers plasma 5-hydroxytryptophan whereas treatment with phentermine had no significant effect. In light of these findings, future research should focus on mechanisms other than increased plasma 5-hydroxytryptophan to explain how fenfluramine increases the risk of primary pulmonary hypertension and valvular heart disease.
引用
收藏
页码:913 / +
页数:4
相关论文
共 21 条
[1]   Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].
Abenhaim, L ;
Moride, Y ;
Brenot, F ;
Rich, S ;
Benichou, J ;
Kurz, X ;
Higenbottam, T ;
Oakley, C ;
Wouters, E ;
Aubier, M ;
Simonneau, G ;
Begaud, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616
[2]  
BAUMANN MH, 2000, IN PRESS SYNAPSE
[3]  
CELADA P, 1992, J CLIN PSYCHOPHARM, V12, P309
[4]   EFFECTS OF CHRONIC TREATMENT WITH DEXFENFLURAMINE ON SEROTONIN IN RAT-BLOOD, BRAIN AND LUNG-TISSUE [J].
CELADA, P ;
MARTIN, F ;
ARTIGAS, F .
LIFE SCIENCES, 1994, 55 (15) :1237-1243
[5]   Valvular heart disease associated with fenfluramine-phentermine [J].
Connolly, HM ;
Crary, JL ;
McGoon, MD ;
Hensrud, DD ;
Edwards, BS ;
Edwards, WD ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588
[6]   Appetite suppressants and valvular heart disease [J].
Devereux, RB .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) :765-767
[7]   Aminorex to fen/phen - An epidemic foretold [J].
Fishman, AP .
CIRCULATION, 1999, 99 (01) :156-161
[8]  
MORITA T, 1983, AM REV RESPIR DIS, V127, P747
[9]  
RALEIGH MJ, 1986, PSYCHOPHARMACOLOGY, V90, P503
[10]  
REDMON B, 1997, NEW ENGL J MED, V337, P1772